2008
DOI: 10.1016/j.atherosclerosis.2007.12.056
|View full text |Cite
|
Sign up to set email alerts
|

Microarray gene profiling of laser-captured cells: A new tool to study atherosclerosis in mice

Abstract: Genetically modified mice susceptible to atherosclerosis are widely used in atherosclerosis research. Although the atherosclerotic lesions in these animals show similarities to those in humans, comprehensive expression profile analysis of these lesions is limited by their very small size. In this communication, we have developed an approach to analyze global gene expression in mouse lesions by a combination of (a) laser capture microdissection (LCM) to isolate RNA from specific lesions, (b) an efficient RNA am… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
11
0

Year Published

2008
2008
2023
2023

Publication Types

Select...
7
1
1

Relationship

2
7

Authors

Journals

citations
Cited by 15 publications
(12 citation statements)
references
References 34 publications
1
11
0
Order By: Relevance
“…RNA was extracted with the PicoPure RNA Isolation Kit (Applied Biosystems). mRNA was submitted to 2 rounds of amplification with the RiboAmp HS RNA Amplification Kit (Applied Biosystems), each of which consisted of synthesis of double‐stranded cDNA using oligo(dT) primers tagged with the T7 promoter sequence, followed by in vitro transcription (IVT) with T7 polymerase 22. A 260 /A 280 ratios and size distribution analysis of amplified cRNAs were assessed with an Agilent 2100 bioanalyzer (Agilent Technologies Inc., Santa Clara, CA).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…RNA was extracted with the PicoPure RNA Isolation Kit (Applied Biosystems). mRNA was submitted to 2 rounds of amplification with the RiboAmp HS RNA Amplification Kit (Applied Biosystems), each of which consisted of synthesis of double‐stranded cDNA using oligo(dT) primers tagged with the T7 promoter sequence, followed by in vitro transcription (IVT) with T7 polymerase 22. A 260 /A 280 ratios and size distribution analysis of amplified cRNAs were assessed with an Agilent 2100 bioanalyzer (Agilent Technologies Inc., Santa Clara, CA).…”
Section: Methodsmentioning
confidence: 99%
“…LCM of macrophages and RNA processing were performed as we previously described. 22 Briefly, %2000 laser shots (power, %65 mV; pulse, %2500 ls) were performed with a Veritas Microdissection System (Applied Biosystems), and cells were collected on CapSure HS LCM Caps (Applied Biosystems). RNA was extracted with the PicoPure RNA Isolation Kit (Applied Biosystems).…”
Section: Lcm and Rna Amplificationmentioning
confidence: 99%
“…28,30 This observation is consistent with the fact that human CRP concentrations can cover a 10 000-fold range (from Ͻ50 g/L to Ͼ500 mg/L) in the acute-phase response, and this is unlikely to be compatible with significant effects of CRP on vascular tone, activation of inflammatory cells, triggering of coagulation, or any of the other purported signaling functions lately ascribed to CRP on the basis of in vitro studies with commercial CRP preparations. Although there is 1 report of enhanced atherosclerosis in apolipoprotein E knockout mice expressing transgenic human CRP, 31 other and larger studies show no such effect [32][33][34] nor any proinflammatory or prothrombotic action even in aged atherosclerotic animals. 35 Furthermore, in the more humanized model of atherosclerosis in LDL receptor knockout mice expressing apolipoprotein B100, transgenic human CRP was found to be atheroprotective.…”
Section: Article See P 2088mentioning
confidence: 99%
“…7,9 Transgenic expression of human CRP protects mice against endotoxin shock and microbial pathogens. 2 Transgenic expression of CRP in apolipoprotein E-null mice has been reported to accelerate, 16,18 to show no effect, 19,20 or even to slow atherosclerosis development. 21 Such divergent results are not easily explained and may reflect inherent difficulties in interpreting results from mouse models of atherogenesis.…”
mentioning
confidence: 99%